News
The drug is already used to treat several autoimmune diseases, including rheumatoid arthritis, ulcerative colitis, and ...
Researchers have hailed an "exciting step forward” in the treatment of type 1 diabetes after finding an arthritis pill can ...
15hon MSN
Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at two-year follow-up
In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of ...
StockStory.org on MSN
Why Tandem Diabetes (TNDM) Stock Is Up Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 5% in the morning session after the company ...
The disease-modifying pill could, used early enough, allow people with type 1 diabetes to be significantly less dependent on insulin treatment.
Tandem Diabetes Care’s Control-IQ+ automated insulin delivery system can lower HbA1c’s in adults with insulin-treated Type 2 diabetes, according to a new study published in the American ...
MedPage Today on MSN
JAK Inhibitor Benefits in Type 1 Diabetes Lost After Discontinuation
The effects of the JAK inhibitor baricitinib (Olumiant) waned after treatment was stopped among patients with new-onset type ...
Type 1 Diabetes (T1D) disrupts the flow of daily life. You don’t drive your kids to school because you fear losing control of your car. You plan school and work and socializing around insulin ...
Medical Device Network on MSN
Insulet gets artistic with Omnipod Mango Pantone colour creation
Insulet’s chief growth officer said: “colour has the power to differentiate a brand,” with mango orange adorning Omnipod’s ...
Polycystic Ovary Syndrome (PCOS) is one of the most common hormonal conditions among women of reproductive age. What many don ...
News-Medical.Net on MSN
Verapamil shows potential for preserving beta-cell function in type 1 diabetes
New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of ...
In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial [1] reported that a daily pill of baricitinib, commonly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results